Barrow, Hanley, Mewhinney & Strauss’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-4,372
Closed -$175K – 351
2020
Q4
$175K Sell
4,372
-7,180
-62% -$232K ﹤0.01% 166
2020
Q3
$283K Sell
11,552
-46,900
-80% -$1.2M ﹤0.01% 168
2020
Q2
$1.06M Buy
58,452
+28,860
+98% +$569K ﹤0.01% 169
2020
Q1
$426K Buy
+29,592
New +$849K ﹤0.01% 233

Other funds holding THC

Barrow, Hanley, Mewhinney & Strauss's THC Position: Q1 2021 in Review

Barrow, Hanley, Mewhinney & Strauss sold out of Tenet Healthcare (THC) in Q1 2021, closing a stake of 4,372 shares — an estimated $175K sold.

Barrow, Hanley, Mewhinney & Strauss first reported a position in THC in Q1 2020 and held it in 4 quarters. The position peaked at $1.06M in Q2 2020. 309 funds tracked by Wall St. Rank hold THC as of Q1 2021.

  • Barrow, Hanley, Mewhinney & Strauss reported no remaining Tenet Healthcare position as of Q1 2021 after selling out during the quarter.
  • Barrow, Hanley, Mewhinney & Strauss sold 4,372 Tenet Healthcare shares in Q1 2021, an estimated $175K.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Tenet Healthcare in Q1 2020 and held it in 4 quarters.
  • Barrow, Hanley, Mewhinney & Strauss's Tenet Healthcare position peaked at $1.06M in Q2 2020.
  • 309 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2021.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q1 2021, filed 13 May 2021.